| Dr Michelle O'shea, MD | |
|
16655 Southwest Freeway, Ste 561, Sugar Land, TX 77479 | |
| (281) 494-3000 | |
| (281) 494-3010 |
| Full Name | Dr Michelle O'shea |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 28 Years |
| Location | 16655 Southwest Freeway, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023040771 | NPI | - | NPPES |
| 8767807 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086X0206X | Surgery - Surgical Oncology | 25MA06656200 (New Jersey) | Secondary |
| 208600000X | Surgery | 25MA06656200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirion, for complex Critical Limb Ischemia (CLI) in Below the Knee (BtK).
The United States is quickly losing ground as the global leader in medical innovation and must pursue coordinated action at the highest levels of government to ensure U.S. competitiveness, create high-paying jobs and find cures to costly and life-threatening diseases, according to a new study prepared by Battelle.
According to WHO statistics, stroke is the second most frequent cause of death worldwide. Cardiac causes account for up to 20% of strokes. Transcatheter occlusion of patent foramen ovale and left atrial appendage eliminate the most important sources for cardiac embolism.
› Verified 2 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirion, for complex Critical Limb Ischemia (CLI) in Below the Knee (BtK).
The United States is quickly losing ground as the global leader in medical innovation and must pursue coordinated action at the highest levels of government to ensure U.S. competitiveness, create high-paying jobs and find cures to costly and life-threatening diseases, according to a new study prepared by Battelle.
According to WHO statistics, stroke is the second most frequent cause of death worldwide. Cardiac causes account for up to 20% of strokes. Transcatheter occlusion of patent foramen ovale and left atrial appendage eliminate the most important sources for cardiac embolism.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle O'shea, MD Po Box 419430, Boston, MA 02241-9430 Ph: (201) 666-3900 | Dr Michelle O'shea, MD 16655 Southwest Freeway, Ste 561, Sugar Land, TX 77479 Ph: (281) 494-3000 |
News Archive
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirion, for complex Critical Limb Ischemia (CLI) in Below the Knee (BtK).
The United States is quickly losing ground as the global leader in medical innovation and must pursue coordinated action at the highest levels of government to ensure U.S. competitiveness, create high-paying jobs and find cures to costly and life-threatening diseases, according to a new study prepared by Battelle.
According to WHO statistics, stroke is the second most frequent cause of death worldwide. Cardiac causes account for up to 20% of strokes. Transcatheter occlusion of patent foramen ovale and left atrial appendage eliminate the most important sources for cardiac embolism.
› Verified 2 days ago
Dr. Robert Morgan Hillery, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 17510 W Grand Pkwy S, Suite 490, Sugar Land, TX 77479 Phone: 713-772-1200 Fax: 281-342-3957 | |
Ulises Baltazar, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 16605 Southwest Fwy, Suite 505, Sugar Land, TX 77479 Phone: 281-240-8400 Fax: 281-240-8405 | |
Mr. Khaja Moinuddeen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 281-238-7870 Fax: 281-633-4985 | |
Michelle Chout-win Shen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 17510 W Grand Pkwy S Ste 190, Sugar Land, TX 77479 Phone: 713-486-1330 | |
Dr. Eric Allen Humble, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 16525 Lexington Blvd, Suite 150, Sugar Land, TX 77479 Phone: 281-313-0555 Fax: 281-313-0554 | |
Dr. Aman Barkat Ali, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16651 Southwest Fwy Ste 450, Sugar Land, TX 77479 Phone: 281-275-0212 Fax: 281-275-0291 |